Global Pharmaceutical Drug Delivery Market Size 2024-2032: Share by Top Brand, Sales, In-Depth Analysis, Growth Forecast

January 31, 2024 06:53 PM AEDT | By EIN Presswire
 Global Pharmaceutical Drug Delivery Market Size 2024-2032: Share by Top Brand, Sales, In-Depth Analysis, Growth Forecast
Image source: EIN Presswire

The growing prevalence of chronic diseases that necessitates improved treatment modalities has augmented the demand for innovative drug delivery solutions.

SHERIDAN, WYOMING, USA, January 30, 2024 /EINPresswire.com/ -- IMARC Group's report titled "Pharmaceutical Drug Delivery Market Report by Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Implantable Drug Delivery, Transmucosal Drug Delivery, Nasal Drug Delivery), Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Others), End User (Hospitals, Ambulatory Surgery Centers, Home Care Settings, Diagnostic Centers, and Others), and Region 2024-2032". The study provides a detailed analysis of the industry, including the global pharmaceutical drug delivery market size, share, trends, and growth forecast.

How big is the pharmaceutical drug delivery market?

The global pharmaceutical drug delivery market size reached US$ 1,397.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,157.1 Billion by 2032, exhibiting a growth rate (CAGR) of 4.8% during 2024-2032.

Request a PDF Sample for more detailed market insights : https://www.imarcgroup.com/pharmaceutical-drug-delivery-market/requestsample

Factors Affecting the Growth of the Global Pharmaceutical Drug Delivery Industry:

• Increasing Prevalence of Chronic Diseases:

The increasing prevalence of chronic diseases worldwide is a major factor propelling the pharmaceutical drug delivery market. Chronic conditions like diabetes, cardiovascular diseases, cancer, and respiratory disorders require long-term and effective management of medications. This has led to a growing demand for advanced drug delivery systems that offer better control of the disease, enhanced patient adherence, and improved quality of life. For instance, the development of insulin pens and pumps has revolutionized diabetes management, allowing for more precise and convenient insulin administration. Similarly, inhalers and nebulizers provide effective drug delivery for respiratory conditions. The need for innovative drug delivery solutions becomes even more critical as the global population ages and the incidence of chronic diseases rises.

• Investments in Research and Development:

Increased investment in research and development (R&D) activities in the pharmaceutical sector is a crucial driver of the drug delivery market. Pharmaceutical companies are investing heavily in R&D to develop new drug formulations and delivery methods to enhance treatment efficacy and patient compliance. This investment is not only focused on developing new drugs but also on improving the delivery mechanisms of existing medications. The aim is to make drugs more effective, safer, and easier to use. For example, R&D in biodegradable polymers for controlled drug release and the development of non-invasive delivery systems like transdermal patches exemplifies this trend. Additionally, collaborations between pharmaceutical companies and drug delivery technology firms are fostering innovation in this field.

• Technological Advancements:

The market is significantly driven by continuous advancements in drug delivery technologies. Innovations in this field aim to enhance the efficacy and safety of drugs by improving their delivery at the target site, minimizing side effects, and ensuring patient compliance. New delivery methods such as nanoparticle-based delivery, targeted delivery systems, and sustained-release formulations are revolutionizing treatment modalities. These technologies enable precise dosing, reduce the frequency of dosing, and can target specific cells or tissues, increasing the therapeutic effectiveness of medications.

Leading Companies Operating in the Global Pharmaceutical Drug Delivery Industry:

• AbbVie Inc.
• Amgen Inc.
• AstraZeneca plc
• Becton Dickinson and Company
• Eli Lilly and Company
• GSK plc
• Johnson & Johnson
• Merck KGaA
• Novartis AG
• Pfizer Inc.
• Sanofi S.A.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure : https://www.imarcgroup.com/request?type=report&id=5796&flag=C

Pharmaceutical Drug Delivery Market Report Segmentation:

By Route of Administration:

• Oral Drug Delivery
• Injectable Drug Delivery
• Topical Drug Delivery
• Ocular Drug Delivery
• Pulmonary Drug Delivery
• Implantable Drug Delivery
• Transmucosal Drug Delivery
• Nasal Drug Delivery

Oral drug delivery represented the largest segment as offers enhanced convenience, patient compliance, and ease of administration.

By Application:

• Infectious Diseases
• Cancer
• Cardiovascular Diseases
• Diabetes
• Respiratory Diseases
• Central Nervous System Disorders
• Autoimmune Diseases
• Others

Infectious diseases holds the largest market share as these diseases are more prevalent and pose global health challenges, requiring effective treatment strategies.

By End User:

• Hospitals
• Ambulatory Surgery Centers
• Home Care Settings
• Diagnostic Centers
• Others

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgery centers, home care settings, diagnostic centers, and others.

By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America leads the market as it has a strong healthcare infrastructure, robust research and development (R&D) capabilities, and rising prevalence of chronic diseases.

Browse Other Market Research Reports:

Dicyclopentadiene Market Share | Statistics Report 2024-2032 : https://www.imarcgroup.com/dicyclopentadiene-market

Electric Rice Cooker Market: Industry Analysis and Forecast 2024-2032 : https://www.imarcgroup.com/electric-rice-cooker-market

Global Liquid Soap Market Share, Trends | Growth Report 2024-2032 : https://www.imarcgroup.com/liquid-soap-market

Long-term Care Software Market Size Report, 2024-2032 : https://www.imarcgroup.com/long-term-care-software-market

Oncology Based In-Vivo CRO Market Size Report, 2024-2032 : https://www.imarcgroup.com/oncology-based-in-vivo-cro-market

Rubber Tired Gantry Crane Market Size, Share Report, 2023-2028 : https://www.imarcgroup.com/rubber-tired-gantry-crane-market

Semiconductor Rectifier Market Size, Share and Demand Analysis 2023-2028 : https://www.imarcgroup.com/semiconductor-rectifier-market

Solvent Market Size, Trends, Research Report, 2024-2032 : https://www.imarcgroup.com/solvent-market

Sports Optic Market Size, Share, Trends and Revenue 2024-2032 : https://www.imarcgroup.com/sports-optic-market

Pharmaceutical Drug Delivery Market Trends:

The increasing development of biologics and complex molecules has driven the demand for innovative drug delivery systems. Delivery methods that ensure stability and controlled release of these molecules are in high demand. Besides, oral drug delivery remains the most preferred route due to its ease of administration and patient compliance.

Advances in oral delivery technologies, such as oral films and nanoparticles, are enhancing drug absorption and bioavailability. Moreover, biodegradable and implantable drug delivery devices are gaining popularity for long-term drug release and targeted therapies. These devices offer convenience and reduce the need for frequent dosing.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

Anand Ranjan
Claight Corporation
+1 6317911145
email us here


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.